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Abstract.  The levels of endogenous basic fibroblast 
growth factor (bFGF) in seven clones of cultured bo- 
vine capillary endothelial (BCE) cells were assayed, 
and their relation to cell morphology, bFGF receptor 
number,  cell migration,  amniotic membrane invasivity, 
and proteinase levels were studied.  Immunoblotting 
experiments with anti-bFGF IgG demonstrated that 
cells from these clones contained different amounts of 
bFGE  The cells containing  high  levels of bFGF had a 
spindle or elongated appearance at confluence and a 
low number of high affinity receptors for bFGF. The 
cells containing  low levels of bFGF had a cobblestone- 
like appearance and a higher number of high affinity 
receptors.  When exposed to 10 ng/ml bFGF, cells con- 
raining  a  low level of bFGF took on an elongated ap- 
pearance with a crisscross pattern similar to that seen 
with the high producer bFGF cells. 
The endogenous bFGF levels of the BCE cell clones 
correlated with the extent Of cell migration  after 
wounding of a monolayer and the degree of invasion 
of the human amniotic membrane.  Cells from the 
clone with the highest endogenous bFGF level 
migrated well, invaded the amnion membrane without 
the addition of exogenous bFGF, and were relatively 
unaffected by the addition of bFGF. Cells from the 
clone containing  the lowest level of bFGF did not mi- 
grate or invade under normal conditions.  However, the 
addition of bFGF to the culture medium strongly en- 
hanced both of these processes. The inclusion of 
anti-bFGF IgG in the media suppressed cell migration 
and invasion.  The plasminogen activator (PA) activities 
of cell lysates of the clones, assayed by the ~2sI-fibrin 
plate technique,  indicated that the PA levels did not 
correlate with the bFGF levels. Metalloproteinase ac- 
tivities in the conditioned medium,  assayed by gelatin 
zymography, correlated with the endogenous bFGF 
levels, suggesting that the degree of expression of 
metalloproteinases might be critical for cell migration 
and invasion.  These data suggest that endogenous 
bFGF may have an important  role for migration  and 
invasion of BCE cells during neovascularization via 
the induction and/or activation of specific metal- 
loproteinases. 
T 
HE formation  of new capillaries,  which takes place 
during embryonic development,  wound healing,  and 
malignant  tumor growth,  involves the migration  and 
proliferation  of capillary endothelial  cells.  Several polypep- 
tides  are  known  which  induce  angiogenesis  (3).  Among 
these  proteins,  basic  fibroblast growth  factor  (bFGF)  ~ is 
one of the more potent angiogenic  factors. The responses of 
capillary endothelial  ceils to bFGF in vitro include changes 
in  cell  morphology,  stimulation  of cell  proliferation  and 
migration,  and increased production of proteinases  such as 
plasminogen  activator (PA) and collagenase (5, 7, 17, 23, 29, 
Please address correspondence to D. B. Rifkin. 
1.  Abbreviations  used  in  this paper:  aMEM,  alpha minimum essential 
medium'; BCE, bovine capillary endothelial; bFGF, basic fibroblast growth 
factor;  PA,  plasminogen activator; rbFGE  recombinant basic fibroblast 
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31). We have recently shown that exogenous bFGF stimulates 
bovine capillary endothelial  (BCE) cells to invade the human 
amniotic  membrane and that this process is dependent upon 
the induction  of proteinases since cell invasion is inhibited 
by specific inhibitors  of serine and metalloproteinases  (16). 
Although bFGF had been thought to exert its effects on en- 
dothelial  ceils via a paracrine  mode,  it has recently been 
shown  that  endothelial  cells produce high  levels  of bFGF 
(22, 34, 36, 37) and that endogenous bFGF is important  for 
endothelial  cell migration  and PA production (32).  During 
the characterization  of several BCE cell clones from bovine 
adrenal  cortices, we observed that the clones of BCE cells 
varied  in their production of endogenous bFGF as well as 
their  phenotypes.  In  this  paper,  we demonstrate  that  the 
endogenous bFGF levels  correlate  with  cell  morphology, 
receptor number,  migration,  invasion,  and proteinase pro- 
duction. These data provide further evidence thatbFGF can 
affect the cellular phenotype in an autocrine manner. 
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Materials 
bFGF was purified from term human placentas as described previously (23, 
29). Recombinant bFGF (rbFGF) was a generous gift from Synergen, Inc. 
(Boulder, CO).  Polyclonal antibodies against placental bFGF were raised 
in rabbits as described (10), and IgG fractions were prepared by either pro- 
tein A-Sepharose column chromatography or bFGF affinity chromatogra- 
phy. This antibody recognized bFGF but no other heparin-binding proteins 
in Western blot or dot blot assays, rbFGF was diluted and stored in alpha 
minimum essential medium (aMEM) (Gibeo Laboratories, Grand Island, 
NY) containing 0.1%  gelatin.  Human urokinase standard was purchased 
from Leo Pharmaceuticals (Copenhagen, Denmark). 
Cell Culture 
Seven clones of  microvascular endothelial cells (8A2, I, 5B4, 2-0, 8C1, 5A2, 
5A5) were isolated from bovine adrenal cortices according to the method 
previously described (4, 6). For the first two passages after isolation, the 
cells were grown in conditioned medium from mouse sarcoma 180 cells. 
This was discontinued after the third passage. Each clone was derived from 
a single cell using cloning plates (4, 6). By convention, these cells are de- 
scribed as capillary endothelial cells although they may be pre- and post- 
capillary endothelial cells. The existence of factor VIII-related antigen in 
cells of the seven clones was confirmed by immunofluorescence (6). Cells 
were seeded on gelatin-coated dishes and grown in aMEM supplemented 
with 5%  calf serum (Flow Laboratories, McLean, Virginia) with 2  mM 
L-glutarnine (Gibeo Laboratories) and 0.14 mg/ml streptomycin, 500 U/ml 
penicillin. Culture  medium was changed twice weekly.  All experiments 
were performed with cells between passages 9 and 14. Comparative studies 
with the clones were conducted with cells which differed by no more than 
one passage number. Unless otherwise noted, cells were always used at den- 
sities slightly below confluence. 
Morphological Observations 
Cells at confluency were washed twice with PBS, fixed with absolute metha- 
nol,  and  stained with Giemsa solution.  Cells were observed and pho- 
tographed with a phase-contrast microscope (E. Leitz, Inc., Wetzlar, FRG). 
Protein Determination 
Protein determinations we~ performed using  the Pierce Chemical Co. 
(Rockford, IL) protein assay reagent according to the manufacturer's in- 
structions. A  standard solution of BSA (Sigma Chemical Co.  St.  Louis, 
MO) including 0.5% SDS or 0.5% Triton X-100 in 0.1 M Tris-HCI buffer 
(pH 8.1) was used as a standard. 
Plasminogen Activator  Assay 
BCE cells in 24-well dishes were incubated overnight in serum-free aMEM 
supplemented with 0.1% gelatin in the presence or absence of rbFGE 
anti-bFGF IgG, or cell extracts. After washing twice with PBS, the cells 
were extracted with 0.5% Triton X-100 in 0.1 M Tris-HCI buffer (pH 8.1). 
Aliquots of cell extract (4.0/~g cell protein) were assayed on t25I-fibrin- 
coated plates as described previously (6). PA activity is presented in PIoug 
units using a urokinase standard. 
Zymography  for MetaUoproteinases 
Zymography for metalioproteinases was carried out using a modification of 
the method of Hen'on et al. (8, 9). BCE cells in 35-ram-diameter culture 
plates were incubated overnight in  1 ml serum-free aMEM. Gelatin dis- 
solved in water (3 mg/ml) and 30% polyacrylamide were mixed and poly- 
merized to make a final gel of 0.1% gelatin and 9% polyacrylamide. The 
amount of conditioned medium assayed was normalized to the  total amount 
of cell protein determined after scraping and assay of the cells. Samples 
were loaded onto the gel without boiling or treatment with/3-mercapto- 
ethanol. After electrophoresis, the gel was cut into two pieces and soaked 
in 2.5% Triton X-100 solution for 1 h. One half of the gel was incubated 
overnight at 37°C in 2 mM CaCI2,  50 mM Tris-HCl buffer (pH 7.6), and 
the other half in the same buffer plus 10 mM EDTA. The gel was stained 
with 0.1%  amido black.  Prestained protein molecular weight standards 
(Bethesda Research Laboratories, Gaitbersburg, MD) were used as nmrkers. 
Immunoblotting 
After washing twice with PBS, subeonfluent BCE cells were immediately 
scraped in 0.5% SDS-containing PBS, boiled for 2 rain, and sonicated. Cell 
lysates and a bFGF standard were loaded on an SDS-polyacrylamide gel 
with a 4% stacking gel and a  14% resolving gel (12).  Upon completion of 
electrophoresis, the samples were transferred for 2 h onto a nitrocellulose 
membrane (Schleicher & Schuell Inc., Keena, NH) using an LKB Instru- 
ments Inc. (Bromma, Sweden) Multiphore II Nova blot system. The blots 
were probed with 200x diluted anti-bFGF IgG for i h at room temperature 
followed by incubation  with t25I-protein A (New England Nuclear,  Boston, 
MA). Competition experiments were carried out with the same amount of 
anti-bFGF IgG which was preincuhated with 50/zg rbFGF for 1 h at room 
temperature. The molecular weight standards used in zymography were also 
used in this assay. 
Receptor  Assay 
Labeling of rbFGF was performed with t25I (7 Ci/mg; New England Nu- 
clear) using Iodo-Gen (Pierce Chemical Co.) as described previously (20, 
25). The number of high affinity binding sites for 125I-bFGF on BCE cells 
was measured as described by Moscatelli (20). Cell number was computed 
by trypsinizing and counting cells from a pair of companion plates of each 
clone. Cells from each clone were plated in 60-ram dishes at a density that 
yielded slightly subconfluent cultures 4 d after plating. Cells were incubated 
with  different concentrations of  t25I-bFGF  in  serum-free aMEM  sup- 
plemented with 0.1% gelatin for 2 h at 4°C. The 125I-bFGF bound to low 
affinity sites was removed with 2  M  NaCI  in Hepes (pH 7.5),  while the 
125I-bFGF bound to high affinity sites was removed with 2 M NaCI in ace- 
tare buffer (pH 4) (20). Receptor numbers were calculated by the method 
of Scatchard (33). 
Cell Migration Assay 
Cell migration was measured according to the method of Sato and Rifkin 
(32). Briefly, confluent monolayers of endothelial cells were wounded with 
a  razor blade and incubated overnight at 37"C in 0.1%  gelatin-containing 
aMEM with rbFGF or anti-bFGF IgG. After the incubation, the cells were 
stained and observed with a light microscope with an occular grid. Migra- 
tion was quantitated by counting the number of cells in successive 125-/~m 
zones from the wound edge. Experiments were done twice, and the data 
shown are averages of eight random fields. 
Invasion Assay 
The amnion invasion assay was performed using chambers covered by hu- 
man amniotic membranes as described (15, 16).  Subconfluent BCE cells 
were labeled with [12~I]iododeo×yuridine  (2,200 Ci/mmol; New England 
Nuclear) in low glucose Dulbecco's medium (Gibco Laboratories) for 24 h, 
trypsinized, and resuspended in growth medium. Cells were seeded in the 
upper compartment (2 cm2; 1 ml) at 1.5  x  105 cell/ml. The effects of an- 
ti-bFGF IgG and rbFGF were examined by adding the reagents to the upper 
compartment before seeding the cells. After a 72-h incubation, the radioac- 
tivity in the amniotic membrane was counted and quantitated as the percent- 
age of  the total radioactivity. Each sample was assayed in six chambers with 
the sample designations masked. Experiments were carried out at least three 
times to confirm reproducibility. 
Results 
During previous studies on the expression of bFGF by en- 
dothelial cells,  we observed that different clones of BCE 
cells, derived from separate isolations, varied in their mor- 
phology.  Because  bFGF  expression  in  bovine aortic  en- 
dothelial cells appeared to affect the cell phenotype (32), we 
characterized several of these microvessel clones in respect 
to properties that might relate to the levels of bFGE 
Morphological Characteristics of  BCE Cell Clones 
To characterize the seven BCE cell clones, we first observed 
their growth properties and morphology. Each clone, when 
split 1:4 for passage, reached confluency between 7 and 10 d 
after seeding. BCE 5A5, 5A2, and 8C1 cells grew 'M0-20% 
The Journal  of Cell Biology,  Volume i 10,  1990  512 Figure I. Morphological characteristics of BCE cell clones. Confluent cultures were fixed and stained with Giemsa. (A-G) Cells cultivated 
in aMEM supplemented with 5% calf serum; (H-J) cells treated with 10 ng/ml bFGF overnight in the same medium. Cells were pho- 
tographed 3 d after confluency.  (A and H) 8A2, (B) I, (C) 5]34, (D and I) 2-0, (E) 8C1, (F and J) 5A2, and (G) 5A5 cells. Bar, 100 #m. 
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the seven clones (200 #g) were separated on SDS-polyacrylamide 
gels (14%). Upon completion of the electrophoresis, the proteins 
were transferred onto a nitrocellulose membrane. The blots were 
probed with anti-bFGF IgG followed by development with ~2~I- 
protein A. (Lanes 1-7) Cell extracts from 8A2, I, 5B4, 2-0, 8C1, 
5A2, and 5A5 clones, respectively; (lane 8) rbFGF (5 ng). 
more rapidly than the other cells. At any time after reaching 
confluence, a small proportion of the 8A2 cells could be seen 
detaching from the dish.  However,  the cultures remained 
confluent, implying that cell division continued. Fig. 1 shows 
the morphology of cells at confluence. Clone 8A2,  I, 5B4, 
and 2-0 cells showed a typical cobblestone-like appearance, 
while BCE 5A2 and 5A5 cells displayed a spindle-shaped or 
elongated morphology. These morphological characteristics 
did not change after reaching confluence as long as the medi- 
um was changed twice a week. 
The addition of 10 ng/ml rbFGF to the confluent cells in- 
duced striking morphological changes in those cells with a 
cobblestone morphology as typified by 8A2 and 2-0 cells 
(Fig.  1, H and I), which became elongated and grew in an 
irregular crisscross pattern.  Under these conditions, BCE 
5A2  cells displayed a  more elongated appearance  with a 
more extensive crisscross pattern (Fig. 1 J). The other four 
cell  clones  showed  similar morphological changes  under 
these conditions (data  not shown).  Since the  addition of 
rbFGF to the cells induced a morphology similar to that of 
5A2 or 5A5 cells, we tested whether the addition of anti- 
bFGF IgG could convert the morphology of BCE 5A2 cells 
from elongated to cobblestone.  However,  the addition of 
anti-bFGF IgG (0.24 mg/ml) to 5A2 cells every other day un- 
til confluency was reached did not induce a significant mor- 
phological change (data not shown). 
Endogenous bFGF  Levels and bFGF  Receptor Number 
The morphological differences of the cells  from different 
clones and their responses to exogenous rbFGF encouraged 
us to examine the endogenous bFGF levels of each clone. To 
visualize the  amount of bFGE  immunoblotting was per- 
formed  using  polyclonal anti-bFGF  antibodies  (Fig.  2). 
Each  clone displayed three  major  immunoreactive bands 
with molecular masses of 24, 22, and 18 kD in addition to 
a 26-kD band which represents nonspecific binding of the 
antibody. Preincubation of  the 50 #g of  antibody with rbFGF 
eliminated the binding to the 18-, 22-, and 24-kD bands but 
not the 26-kD band, thereby demonstrating the specificity of 
the reaction (data not shown). The lowest molecular mass 
band (18 kD) had the same size as purified rbFGE The larger 
bFGF forms (24 and 22 kD) have been observed previously 
in endothelial cells (Renko, M., personal communication) 
and appear to represent bFGF forms extended at the amino- 
terminal end (2,  28,  35).  Immunoblotting clearly demon- 
strated that 5A2 and 5A5 cells contained the highest amount 
of  bFGF, 8A2 cells the lowest, and I, 51M, 2.0, and 8C1 were 
intermediate. These data were corroborated by monitoring 
the ability of cell extracts from each clone to induce PA in 
BCE cells. This assay has been shown previously to provide 
a  simple and quantitative assay for bFGF (22).  The same 
rank order of bFGF levels was also observed in this assay 
(data not shown). 
bFGF receptor binding assays with cells from the various 
clones showed a distribution with the 8A2 cells, having the 
lowest bFGF content and the highest number of receptors, 
and the 5A5 cells, having the highest bFGF content and the 
lowest number of receptors (Table I). All clones had ,,o7 x 
1@ low affinity binding sites per cell (data not shown). The 
addition of 10 ng/ml of rbFGF to 8A2, 2-0, and 5A2 cultures 
caused a downregulation of the number of receptors in each 
cell type (Table I). 8A2 cells showed the greatest degree of 
downregulation, while 5A2 cells showed the least. The addi- 
tion of anti-bFGF IgG to the cultures did not change the 
binding constants for 8A2, 2.0, or 5A2 cells (data not shown). 
Thus, there appeared to be an inverse relationship between 
bFGF production and receptor number. This is in agreement 
with an earlier proposal by Moscatelli (20)  that an inverse 
relationship may exist between endogenous bFGF and recep- 
tor number. 
Cell Migration and Invasion Assays 
Since we had shown previously that endothelial cell migra- 
tion and invasion were dependent upon bFGF (16, 32), we 
compared cells from each of the clones with respect to these 
properties.  The  cell  migration  assay  was  performed  by 
counting the cells that migrated into a denuded area formed 
by scraping a confluent monolayer with a razor blade. BCE 
5A2 cells were the most migratory, while the 8A2 cells were 
the least (Fig. 3). The degree of  migration of  the other clones 
was roughly in the same order as observed for other proper- 
ties, with 5B4 and I cells migrating poorly and 5A5 cells 
migrating well. Exogenous rbFGF stimulated the migration 
of cells from 5A2, 2-0 and 8A2 clones. However, the degree 
Table L Quantitation of  High Affinity Binding Sites on Cells 
from Different Clones 
Sites/cell ( x 103) 
after  incubation with 
Cell clone  Sites/cell (x 103)  10 ng/ml bFGF 
8A2  21.0  7.5 
2-0  9.0  4.5 
5A2  7.2  4.2 
I  12.0  ND 
5B4  14.4  ND 
8C1  13.0  ND 
5A5  6.0  ND 
Receptor binding assays were done as described  in Materials and Methods. 
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Figure 3. Cell migration assay. Confluent monolayers of endothelial 
cells were wounded with a razor blade and incubated overnight in 
the absence or presence of rbFGF or anti-bFGF IgG. The number 
of cells that migrated into the denuded area was counted as de- 
scribed in Materials and Methods. The difference in cell densities 
in the unwounded area in seven clones was <10%. (Bars 1-3) Basal 
migration, migration in the presence of 10 ng/ml rbFGF, and migra- 
tion in the presence of 20/~g/ml anti-bFGF IgG purified by bFGF 
affinity chromatography, respectively. Data illustrated are the means 
of eight random fields. Standard errors are shown. 
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Figure 4. Amnion invasion assay. The invasivity of three BCE cell 
clones  into the  human  amniotic  membrane  was examined using 
[t25I]iododeoxyuridine-labeled cells according  to the method de- 
scribed  in the text. The radioactivity  in the membrane  (invaded 
ceils) is presented as the percentage of the total initial radioactivity. 
The background  is the radioactivity bound nonspecifically to the 
membrane. This value is obtained by inserting an 0.4-/~m nucleo- 
pore filter between the seeded cells and the amniotic membrane and 
measuring the amount of radioactivity in the membrane after 72 h. 
The data shown are the average of six samples. (Bars I and 2) Inva- 
sivity of cells in the absence of bFGF and invasivity of cells in the 
presence  of 10  ng/ml  rbFGF,  respectively.  Standard  errors are 
shown. 
bFGF expression, we measured the amounts of PA in cell ly- 
sates. The PA levels, as measured by the PA plate assay, var- 
ied in a  manner that did not relate to the other properties 
(Fig. 5). Zymographic analysis and reverse fibrin zymogra- 
phy from the same sample indicated that differences in PA 
of migration of 8A2 ceils did not exceed the level observed 
with 5A2 cells. Anti-bFGF IgG inhibited the migration of all  aO - 
three clones. In addition, the distance that the cells migrated 
from the wound edge was greatest with 5A2 and 5A5 cells 
and least with 8A2 cells (data not shown). These data suggest  25 
that high levels of endogenous bFGF increased the distance 
that the  cells  moved as  well  as the  number of cells  that 
migrated.  20 
The ability of cells from three of the clones to invade the 
amniotic membrane was monitored in the presence or ab- 
sence of rbFGE BCE cells normally do not penetrate the am-  ~  15 
niotic membrane as shown by Mignatti et al.  (16).  As ex-  < 
petted, BCE 8A2 cells hardly invaded the membrane (Fig.  a. 
4).  However, 2-0 and 5A2 ceils invaded the amnion under  10 
normal conditions, with 5A2 cells being slightly more inva- 
sive. The inclusion of 10 ng/ml of rbFGF in the upper cham- 
ber potentiated the invasion by cells from each clone. How-  5 
ever, the degree of potentiation was greatest with 8A2 cells 
and least with 5A2 cells. This effect was neutralized by the 
addition of anti-bFGF IgG (data not shown).  O' 
PA and Metalloproteinase Activities 
Numerous reports have indicated that the levels of specific 
proteinases, such as PA and collagenase, correlate with cell 
invasivity (1, 14, 15, 21, 24, 30) and that endothelial cells ex- 
press these proteinases (6-9, 11, 13, 16-19, 27). To establish 
whether  proteinase  levels  correlated  with  the  degree  of 
8A2  I  5B4  2-0  81315A2  5A5 
Figure 5. PA assays. PA activities of seven BCE cells clones were 
determined.  BCE  cells  were  incubated  overnight  in serum-free 
media. The cells were extracted with 0.5% Triton X-100 in 0.1 M 
Tris-HC1 buffer (pH 8.1). 4/zg of cell extract was assayed using the 
~25I-fibrin plate assay. PA activity  is presented  in Ploug units/#g 
cell protein. Data shown are the mean of duplicate samples. Stan- 
dard errors are shown. 
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tioned media were assayed for metalloproteinases  as described in 
Materials and Methods. The gel was incubated in 2 mM CaCI2, 50 
mM Tris-HCl buffer (pH 7.6). (Lanes 1-7) 8A2, I, 2-0, 8C1, 5B4, 
5A2, and 5A5 cells, respectively. 
levels were not the result of differences in PA inhibitor 1 lev- 
els  (data not shown).  However, the addition of 10  ng/ml 
rbFGF to the medium induced a prominent stimulation of PA 
levels in 8A2 cells, a moderate stimulation in 2-0 cells, and 
a poor stimulation in 5A2 cells (data not shown). This effect 
correlated with endogenous bFGF levels.  Anti-bFGF IgG 
added to the cultures suppressed the level of PA activity as 
described earlier (32)  (data not shown). 
The activities of metaUoproteinases were assayed by gela- 
tin zymography (Fig. 6). The media conditioned by the vari- 
ous cells contained a major gelatinolytic activity with a mo- 
lecular mass of 64 kD. Those clones that had high levels of 
the 64-kD enzyme also had minor activities with masses of 
94 and 57  kD.  These three bands were also seen in cell 
extracts but in lower amounts (data not shown). All of the 
gelatinolytic activities were completely blocked by the ad- 
dition of 10 mM EDTA (data not shown). The molecular 
weights of three lytic bands are similar or identical with pre- 
viously reported gelatinolytic metalloproteinases from rab- 
bit brain capillary endothelial cells (9). The 64-kD band may 
correspond to the type IV collagenase, while the 94-kD band 
appears similar to a gelatinase found in several cell types (9). 
The intensities of the 64-kD band in media correlated with 
the bFGF levels in the clones. 5A5 cells produced the highest 
amount of enzyme, while 8A2  cells produced the lowest 
amount. This result is consistent with the proposed require- 
ment for type IV collagenase in endothelial cell invasion (16). 
Discussion 
These experiments demonstrate that a heterogeneity exists 
among seven clones of BCE cells with respect to endogenous 
bFGF levels.  The results also indicate that the endogenous 
bFGF levels in BCE cells correlate with the cell morphology, 
high affinity receptor number, the degree of cell migration, 
the  invasion of the arnnion membrane,  and  the  levels of 
metaUoproteinase production. 
BCE cells from the clone with the highest bFGF level had 
an elongated morphology, while cells with the lowest bFGF 
level retained a cobblestone morphology. Several additional 
other reports  have described a  change in endothelial cell 
morphology upon exposure to bFGF (17, 23). These observa- 
tions suggest that endogenous bFGF levels and endothelial 
cell morphology are closely correlated. 
Cell migration and invasion also correlated directly with 
the level  of endogenous bFGE  These responses were in- 
versely proportional to the numbers of  high affinity  receptors 
for bFGF, indicating that receptor number may be down- 
regulated by the level of bFGE The migration and invasion 
of the low bFGF-containing cells was increased in the pres- 
ence of exogenous bFGF. However, the degree of migration 
and invasion never exceeded that observed with the high 
bFGF-producing cells, suggesting that BCE cells may have 
a defined limit to their response to either endogenous or ex- 
ogenous bFGE 
Previously, we demonstrated that invasion of the amniotic 
membrane by BI6 melanoma cells and BCE cells was sup- 
pressed by inhibitors and/or antibodies to PA and collagenase 
and that there may be linkage in activities between these two 
proteinases (15, 16). In the present study, the levels of metal- 
loproteinase activities were found to correlate with bFGF 
levels and, thus, with the invasivity of the cells; however, the 
PA activities did not. This agrees with our previous data, 
suggesting metalloproteinases as the final step in a cascade 
of proteolytic activations required for invasion (11, 15). The 
lack of a correlation between PA levels and the degree of 
invasion may indicate that, once a minimal level of PA pro- 
duction is achieved to insure sufficient activation of procol- 
lagenase, further increases in PA activity are of little conse- 
quence. Alternatively, a recent report by Ossowski (26) has 
shown that only receptor-bound urokinase-type PA is critical 
for invasion.  Therefore,  it is  possible that the amount of 
receptor-bound urokinase-type PA in these BCE cells may 
correlate with bFGF concentrations. At present, it is not pos- 
sible to measure this parameter for the different BCE clones 
since pure bovine urokinase-type PA is  not available  and 
receptor binding displays a species specificity. 
In these experiments, some of the BCE clones used were 
isolated from individual bovine adrenal cortices. We have no 
idea of the precise vascular origin of these cells other than 
that they are from the adrenal cortex microvasculature. Our 
isolation procedure does not permit us to differentiate between 
true capillary endothelial cells and cells from postcapillary 
venules or small arterioles. It is interesting to speculate, how- 
ever,  whether within a single microvessel endothelial cells 
vary in properties such as bFGF production and whether this 
may relate to unique functional roles during processes such 
as angiogenesis. Thus, only certain cells may initiate capil- 
lary invasion, while others may simply divide to provide the 
additional cells required for the elongating vessel. 
Since cells with high levels of bFGF may have a growth 
advantage  compared  with  cells  producing  low  levels  of 
bFGF, the high levels of bFGF found in many cultured cells 
may represent a tissue culture selection artifact as these cells 
would be easier to establish in culture. Thus, in vivo bFGF 
levels may be  significantly lower than those observed  in 
vitro. A potential biological advantage of this state is that 
bFGF production could be induced by specific agents under 
the appropriate conditions. The 8A2 cells may provide a cell 
strain to assay for such agents that induce bFGF synthesis. 
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